Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
- PMID: 21109068
- DOI: 10.1016/j.antiviral.2010.09.005
Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
Abstract
A significant number of women, especially in developing countries, need protection against more than one sexually transmitted infection (STIs), for instance HIV-1 and HSV-2, and family planning methods to prevent unwanted pregnancies. Dual protection technologies (DPTs; also known as multipurpose technologies) are designed to address two different indications with one product. Examples of DPTs are vaginal products capable of preventing transmission of HIV-1 in women while simultaneously providing contraceptive properties and a vaginal product capable of reducing HIV-1 transmission while preventing transmission of a second STI. DPTs can be categorized into three main approaches: 1) physical barriers, 2) chemical barriers, and 3) a combination of physical and chemical barriers. Examples of physical barriers are male and female condoms, diaphragms and cervical caps. Chemical barriers include use of a single drug with two mechanisms of action (viz., dual-activity compounds with microbicidal and contraceptive properties or activity against HIV-1 and a second STI pathogen such as HSV-2) or a combination of two drugs each targeted against separate mechanisms for achieving contraception and inhibition of HIV-1. Combinations of chemical and physical barriers are based on physical barriers such as a diaphragm along with a microbicide. Examples of each approach and current prototypes (such as vaginal gels and intravaginal rings) under development are described in this paper. Challenges facing development and regulatory approval of DPTs are also reviewed. This article forms part of a special supplement on a presentation covering DPTs, based on the symposium "Trends in Microbicide Formulations", held on 25 and 26 January 2010, Arlington, VA.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.Antiviral Res. 2010 Dec;88 Suppl 1:S55-66. doi: 10.1016/j.antiviral.2010.09.006. Antiviral Res. 2010. PMID: 21109069
-
Advances in microbicide vaginal rings.Antiviral Res. 2010 Dec;88 Suppl 1:S30-9. doi: 10.1016/j.antiviral.2010.09.003. Antiviral Res. 2010. PMID: 21109066 Review.
-
Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers.Antiviral Res. 2010 Dec;88 Suppl 1:S10-8. doi: 10.1016/j.antiviral.2010.09.018. Antiviral Res. 2010. PMID: 21109063 Review.
-
Future strategies in microbicide development.Best Pract Res Clin Obstet Gynaecol. 2012 Aug;26(4):503-13. doi: 10.1016/j.bpobgyn.2012.02.001. Epub 2012 Mar 10. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22406260 Review.
-
Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.Expert Opin Drug Deliv. 2012 Apr;9(4):417-27. doi: 10.1517/17425247.2012.668183. Epub 2012 Mar 2. Expert Opin Drug Deliv. 2012. PMID: 22385316 Review.
Cited by
-
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.Best Pract Res Clin Obstet Gynaecol. 2012 Aug;26(4):451-62. doi: 10.1016/j.bpobgyn.2012.01.004. Epub 2012 Feb 4. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22306523 Free PMC article. Review.
-
How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa.PLoS One. 2013 Dec 30;8(12):e83193. doi: 10.1371/journal.pone.0083193. eCollection 2013. PLoS One. 2013. PMID: 24386160 Free PMC article.
-
The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.J Int AIDS Soc. 2018 Mar;21(3):e25064. doi: 10.1002/jia2.25064. J Int AIDS Soc. 2018. PMID: 29537654 Free PMC article.
-
Translation of biomedical prevention strategies for HIV: prospects and pitfalls.J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1(0 1):S12-25. doi: 10.1097/QAI.0b013e31829202a2. J Acquir Immune Defic Syndr. 2013. PMID: 23673881 Free PMC article. Review.
-
Reproductive Life Goals: A Systematic Review of Pregnancy Planning Intentions, Needs, and Interventions Among Women Involved in U.S. Criminal Justice Systems.J Womens Health (Larchmt). 2021 Mar;30(3):412-428. doi: 10.1089/jwh.2019.7951. Epub 2020 Jun 23. J Womens Health (Larchmt). 2021. PMID: 32589492 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous